AstraZeneca Pharma India Limited

BSE:506820 Stock Report

Market Cap: ₹159.5b

AstraZeneca Pharma India Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of 506820?
Owner TypeNumber of SharesOwnership Percentage
State or Government104,3070.417%
Institutions1,808,9267.24%
Individual Insiders1,983,0977.93%
General Public2,353,6709.41%
Public Companies18,750,00075%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.

Top Shareholders

Top 25 shareholders own 90.59% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
75%
AstraZeneca PLC
18,750,000₹119.6b0%no data
2.92%
Nippon Life India Asset Management Limited
729,018₹4.7b0.2%0.12%
2.68%
Tejas Trivedi
669,078₹4.3b0%no data
2.4%
Shivani Trivedi
600,299₹3.8b0%no data
1.84%
Minaxi Trivedi
460,720₹2.9b0%no data
1.43%
ICICI Prudential Asset Management Company Limited
357,955₹2.3b-6.23%0.04%
1.01%
Prashant Jain
253,000₹1.6b0%no data
0.98%
The Vanguard Group, Inc.
245,208₹1.6b0%no data
0.51%
Bandhan AMC Limited
127,305₹812.0m2.64%0.12%
0.47%
BlackRock, Inc.
118,489₹755.8m-0.05%no data
0.42%
Investor Education and Protection Fund (IEPF)
104,307₹665.3m0%no data
0.34%
State Street Global Advisors, Inc.
85,652₹546.4m4.69%no data
0.22%
Norges Bank Investment Management
53,949₹344.1m0%no data
0.14%
Dimensional Fund Advisors LP
34,956₹223.0m5.92%no data
0.14%
Baroda BNP Paribas Mutual Fund
34,200₹218.2m0%0.09%
0.022%
Teachers Insurance and Annuity Association-College Retirement Equities Fund
5,453₹34.8m0%no data
0.017%
SBI Funds Management Limited
4,265₹27.2m11.4%no data
0.015%
Mirae Asset Global Investments Co., Ltd.
3,851₹24.6m11.6%no data
0.015%
Motilal Oswal Asset Management Company Limited
3,733₹23.8m2.27%no data
0.014%
HDFC Asset Management Company Limited
3,556₹22.7m18%no data
0.0022%
American Century Investment Management Inc
558₹3.6m0%no data
0.0015%
Groww Asset Management Limited
384₹2.5m12%0.03%
0.0012%
Edelweiss Asset Management Limited
308₹2.0m14.5%no data
0.00029%
Axis Asset Management Company Limited
73₹462.5k0%no data
0.00005%
Peerless Funds Management Co., Ltd.
13₹79.7k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 20:03
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2024/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

AstraZeneca Pharma India Limited is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kameswari V. S. ChavaliFirstCall Research